Position
SIMPLEX TRADING, LLC in Gain Therapeutics, Inc.
Back to the book · All holders of GANX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$17.2K$3.22 → $1.94
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 47.9K | $154.4K | — | — | — | 0.0% |
| Q1 2026 | 13.4K | $26.1K | $1.94 | −$17.2K | −$111.1K | 0.0% |